Hillner, B E <br/><br/>
Potential evaluation of the incremental cost-effectiveness of paclitaxel in advanced non-small-cell lung cancer (Eastern Cooperative Oncology Group 5592).  [electronic resource] 

 -  Journal of the National Cancer Institute. Monographs  1995 
 - 65-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1052-6773 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials, Phase III as Topic--economics<br/>Cost-Benefit Analysis<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage